Focuses on the method for payment of drugs brought about by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 in the U.S.. Amelioration of the impact of Medicare's hospital outpatient prospective payment system on medical care; Effort of the government to control escalating medical costs; Decline of payment rates for sole-source drugs.